Bangjiang Fang
- Molecular Biology
- Infectious Diseases
- Complementary and alternative medicine top 10%
- Epidemiology
- Pharmacology top 10%
- Topics
- COVID-19 Clinical Research Studies (14 papers)SARS-CoV-2 and COVID-19 Research (9 papers)Sepsis Diagnosis and Treatment (7 papers)
- Partner nations
- ChinaUnited KingdomMacao
In The Last Decade
Bangjiang Fang
49 papers receiving 367 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 103
- Infectious Diseases 76
- Complementary and alternative medicine 63
- Epidemiology 56
- Pharmacology 48
Countries citing papers authored by Bangjiang Fang
This map shows the geographic impact of Bangjiang Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bangjiang Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bangjiang Fang more than expected).
Fields of papers citing papers by Bangjiang Fang
This network shows the impact of papers produced by Bangjiang Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bangjiang Fang. The network helps show where Bangjiang Fang may publish in the future.
Co-authorship network of co-authors of Bangjiang Fang
This figure shows the co-authorship network connecting the top 25 collaborators of Bangjiang Fang. A scholar is included among the top collaborators of Bangjiang Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bangjiang Fang. Bangjiang Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 16 | |
| 14 | 13 | |
| 15 | 1 | |
| 16 | 4 | |
| 17 | 7 | |
| 18 | 2 | |
| 19 | 9 | |
| 20 | 1 |
About Bangjiang Fang
Bangjiang Fang is a scholar working on Complementary and alternative medicine, Critical Care and Intensive Care Medicine and Pharmacology, having authored 58 papers that have together received 374 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Sepsis Diagnosis and Treatment (7 papers). The work is most often cited by research in Complementary and alternative medicine (63 citations), Applied Microbiology and Biotechnology (12 citations) and Pharmacology (48 citations). Bangjiang Fang has collaborated with scholars based in China, United Kingdom and Macao. Frequent co-authors include Jun Feng, Fangyuan Sun, Gang Chen, Xinxin Wu, Min Cao, Caiyu Chen, Yuxia Sun, Daixing Zhou, Gang Yu and Daqian Zhan. Their work appears in journals such as Journal of Ethnopharmacology, Medicine and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.